Eyemuse Health
Menu
Contact
  • About
  • Benefits
  • Science
  • News & Media Coverage
    • Press Releases
    • Media Coverage
  • Contact Us
    • Get Updates

EYEMUSE™ News

  • Kyowa Hakko Launches Clinically-Researched Paraprobiotic for Eye Health

    15 April 2021

    View on NutraIngredients.com »

  • Kyowa Hakko Flags Immunity-Eye Health Connection

    09 April 2021

    View on NutritionInsight.com »

  • Kyowa Hakko Launches Paraprobiotic Eye Health Ingredient

    08 April 2021

    View on NutritionalOutlook.com »

  • Kyowa Hakko Announces Scientific-Breakthrough for Eye Health - EYEMUSE™ Enters the U.S. Market

    06 April 2021 New York, NY

    Kyowa Hakko, global leaders in the research, manufacturing and purification of high-quality health ingredients, is thrilled to introduce a new perspective on eye health. Its breakthrough clinically-researched eye health ingredient, EYEMUSE™, is entering the U.S. market, becoming the first heat-treated probiotic strain for healthy eye function, discovered by Kyowa Hakko’s parent-company Kirin Holdings Co., Ltd. Read More ›

Interested in EYEMUSE™? Subscribe to updates.

Subscribe to updates Subscribe for updates
Kirin logo      Kyowa logo
Home | Get News Alerts | Privacy Policy | Kyowa Hakko USA | Kyowa Hakko Bio | Kirin Holdings | Contact Us | Kyowa Partner Toolkit

EYEMUSE™ is a clinically researched lactic acid bacteria developed by Kirin Holdings Co., Ltd.

Copyright © 2023 by KYOWA HAKKO U.S.A., INC. All Rights Reserved. | AWS

† Formerly known and referred in studies as Lactobacillus paracasei KW3110

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.